NCT00782314已完成不适用
Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 400
- 试验地点
- 1
- 主要终点
- to determine the efficacy of both possible treatment approaches with Symbicort® Turbuhaler®, measured by asthma control
研究概览
简要总结
We want to evaluate efficacy of Symbicort® Turbuhaler® (formoterol/budesonide) therapy for asthma in real life conditions. For this purpose we will include both patients that are treated with Symbicort® Turbuhaler® the "classical" maintenance only treatment approach as well as those treated with the SMART approach.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients diagnosed with persistent asthma treated with Symbicort® Turbuhaler® in line with its label
- •non-pregnant females
- •existing maintenance only treatment with Symbicort® Turbuhaler® 80 μg/4,5 μg, 160 μg/4,5 μg or 320 μg/9 μg for at least 1 month
- •existing SMART treatment with Symbicort® Turbuhaler® 80 μg/4,5 μg or 160 μg /4,5 μg for at least 1 month
排除标准
- •patients not being treated with Symbicort® Turbuhaler®
- •patients treated with Symbicort® Turbuhaler® for COPD
结局指标
主要结局
to determine the efficacy of both possible treatment approaches with Symbicort® Turbuhaler®, measured by asthma control
时间窗: three times: 0, 3, 6 months after inclusion
次要结局
- to determine the number of maintenance and reliever inhalations of Symbicort® Turbuhaler®, as well as the concomitant usage of a separate reliever inhaler even in the case of SMART treatment approach(three times: 0, 3, 6 months after inclusion)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With AsthmaAsthmaNCT02224157AstraZeneca4,215
已完成
3 期
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.AsthmaNCT02149199AstraZeneca3,850
已完成
3 期
Prevention of Asthma Relapse After Discharge From EmergencyAsthmaNCT00326053AstraZeneca600
已完成
3 期
A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in JapanChronic Obstructive Pulmonary DiseaseNCT01070784AstraZeneca328
已完成
不适用
A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®AsthmaNCT00532922AstraZeneca310